Ahmad F. Mahmoud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmad F. Mahmoud has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Erica R. Thaler
From the Department of Otolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.
2 shared publications- Erica R. Thaler
Department of Otorhinolaryngology‐Head and Neck Surgery University of Pennsylvania Philadelphia Pennsylvania USA
2 shared publications - Jason Lee Yu
Department of Otolaryngology, Emory University School of Medicine, Atlanta, USA
2 shared publications Adam C. McCann
Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, Kansas
1 shared publicationAdam R. Gigliotti
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, United States
1 shared publicationBert W. O'MAlley
Department of Otorhinolaryngology-Head and Neck Surgery
1 shared publication
Latest Publications
- 7 May 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (4) , 1085-1089
Upper airway stimulation therapy and sleep architecture in patients with obstructive sleep apnea
Objectives/Hypothesis: To quantify changes in sleep architecture before and after upper airway stimulation (UAS) therapy in patients with obstructive sleep apnea.Study Design: Retrospective chart review.Methods: This study was performed at a single‐institution tertiary academic care center. Patients who responded successfully to UAS implantation were selected for this study. Preoperative and postoperative sleep studies were compared to determine sleep architecture changes. Primary outcomes included sleep architecture parameters such as N1, N2, N3, and rapid eye movement (REM) in addition to others. Secondary outcomes included body mass index.Results: Thirty‐five patients met inclusion criteria for this study. There was significant improvement across several sleep architecture parameters. N1 sleep percent decreased from 16.7% ± 2.1% preoperatively to 10.1% ± 1.6% postoperatively (P = .023). Time spent in N2 increased from 148.0 ± 12.4 minutes to 185.5 ± 10.4 minutes (P = .030), whereas N3 increased from 21.9 ± 5.0 minutes to 57.0 ± 11.1 minutes (P = .013). No significant changes were observed in REM sleep. Arousal index decreased from 38.8 ± 4.0 to 30.3 ± 4.0 (P = .050).Conclusions: There was significant improvement across several sleep architecture parameters among patients who responded successfully to UAS implantation.Level of Evidence: 4Laryngoscope, 130:1085–1089, 2020
- 7 May 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (4) , 1085-1089
Upper airway stimulation therapy and sleep architecture in patients with obstructive sleep apnea
Objectives/Hypothesis: To quantify changes in sleep architecture before and after upper airway stimulation (UAS) therapy in patients with obstructive sleep apnea.Study Design: Retrospective chart review.Methods: This study was performed at a single‐institution tertiary academic care center. Patients who responded successfully to UAS implantation were selected for this study. Preoperative and postoperative sleep studies were compared to determine sleep architecture changes. Primary outcomes included sleep architecture parameters such as N1, N2, N3, and rapid eye movement (REM) in addition to others. Secondary outcomes included body mass index.Results: Thirty‐five patients met inclusion criteria for this study. There was significant improvement across several sleep architecture parameters. N1 sleep percent decreased from 16.7% ± 2.1% preoperatively to 10.1% ± 1.6% postoperatively (P = .023). Time spent in N2 increased from 148.0 ± 12.4 minutes to 185.5 ± 10.4 minutes (P = .030), whereas N3 increased from 21.9 ± 5.0 minutes to 57.0 ± 11.1 minutes (P = .013). No significant changes were observed in REM sleep. Arousal index decreased from 38.8 ± 4.0 to 30.3 ± 4.0 (P = .050).Conclusions: There was significant improvement across several sleep architecture parameters among patients who responded successfully to UAS implantation.Level of Evidence: 4Laryngoscope, 130:1085–1089, 2020
- 19 November 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (6) , 1395-1399
Novel approach using transoral robotic surgery for resection of cervical spine chordoma
Chordomas are rare, infiltrative neoplasms of notochordal origin that present along the spinal canal; en bloc surgical resection is paramount to successful treatment. Limited visualization and complex anatomy are major challenges to resection of upper cervical spine chordomas and often require invasive surgery. A 27‐year‐old male presented with an incidentally discovered chordoma of the midline second cervical vertebra of the spine. To obtain en bloc resection of the lesion while both overcoming limitations due to access and without introducing morbidity from traditional anterior approaches, we elected using transoral robotic surgery for resection. Due to complete resection, the patient remains disease‐free and was spared adjuvant radiation. Laryngoscope, 129:1395–1399, 2019
- 19 November 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (6) , 1395-1399
Novel approach using transoral robotic surgery for resection of cervical spine chordoma
Chordomas are rare, infiltrative neoplasms of notochordal origin that present along the spinal canal; en bloc surgical resection is paramount to successful treatment. Limited visualization and complex anatomy are major challenges to resection of upper cervical spine chordomas and often require invasive surgery. A 27‐year‐old male presented with an incidentally discovered chordoma of the midline second cervical vertebra of the spine. To obtain en bloc resection of the lesion while both overcoming limitations due to access and without introducing morbidity from traditional anterior approaches, we elected using transoral robotic surgery for resection. Due to complete resection, the patient remains disease‐free and was spared adjuvant radiation. Laryngoscope, 129:1395–1399, 2019
- 12 September 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (1) , 256-258
Transoral robotic surgery versus upper airway stimulation in select obstructive sleep apnea patients
Objectives: Transoral robotic surgery (TORS) has been used to treat obstructive sleep apnea (OSA) since 2009, with recent meta‐analysis showing an average reduction of apnea‐hypopnea index (AHI) from 44.3 to 17.0. In 2014, upper airway stimulation surgery (UAS) was approved for OSA treatment, with results showing an average AHI reduction from 32.0 to 15.3. Given there was a period when TORS was available and UAS was not, we looked at a subset of patients treated with TORS but who could have qualified for UAS and compared their outcomes to patients who received UAS.Methods: This is a retrospective chart review comparing TORS to UAS in treatment of OSA performed by a single surgeon between 2011 and 2016. Inclusion criteria were a body mass index less than 35 and AHI between 20 and 65 consistent with criteria for UAS implantation. Patients who received TORS and met the inclusion criteria had their preoperative drug‐induced sleep endoscopy recordings re‐evaluated. Patients with anteroposterior retropalatal collapse that would have qualified them for UAS had their outcomes compared to patients who received UAS.Results: Results between TORS and UAS showed an average AHI reduction of 12.7 and 33.3, respectively. Overall cure rate, defined as AHI < 5, was 10.0% and 70.3%, respectively.Conclusion: Results of this study indicate that, when met with criteria for both TORS and UAS, patients receiving UAS had greater improvement in several objective measures of OSA. Studies like this may help direct future treatment algorithms for surgical management of OSA.Level of Evidence: 4 Laryngoscope, 129:256–258, 2019
- 12 September 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (1) , 256-258
Transoral robotic surgery versus upper airway stimulation in select obstructive sleep apnea patients
Objectives: Transoral robotic surgery (TORS) has been used to treat obstructive sleep apnea (OSA) since 2009, with recent meta‐analysis showing an average reduction of apnea‐hypopnea index (AHI) from 44.3 to 17.0. In 2014, upper airway stimulation surgery (UAS) was approved for OSA treatment, with results showing an average AHI reduction from 32.0 to 15.3. Given there was a period when TORS was available and UAS was not, we looked at a subset of patients treated with TORS but who could have qualified for UAS and compared their outcomes to patients who received UAS.Methods: This is a retrospective chart review comparing TORS to UAS in treatment of OSA performed by a single surgeon between 2011 and 2016. Inclusion criteria were a body mass index less than 35 and AHI between 20 and 65 consistent with criteria for UAS implantation. Patients who received TORS and met the inclusion criteria had their preoperative drug‐induced sleep endoscopy recordings re‐evaluated. Patients with anteroposterior retropalatal collapse that would have qualified them for UAS had their outcomes compared to patients who received UAS.Results: Results between TORS and UAS showed an average AHI reduction of 12.7 and 33.3, respectively. Overall cure rate, defined as AHI < 5, was 10.0% and 70.3%, respectively.Conclusion: Results of this study indicate that, when met with criteria for both TORS and UAS, patients receiving UAS had greater improvement in several objective measures of OSA. Studies like this may help direct future treatment algorithms for surgical management of OSA.Level of Evidence: 4 Laryngoscope, 129:256–258, 2019
- Open Access
- 14 August 2018
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 8, 312
Management of the Airway for Transoral Robotic Supraglottic Partial Laryngectomy
Introduction: Over the last several decades, transoral resection techniques for treatment of supraglottic lesions have become increasingly favored to reduce the need for either open transcervical resection or primary chemoradiation. Transoral robotic surgery (TORS) offers advantages in visualization, dissection control, and access to remove bulky tumors en bloc. However, the management of the airway for these cases tends to vary, without clear guidelines as to when a tracheostomy is necessary. Materials and Methods: A retrospective review of all patients who underwent transoral robotic supraglottic partial laryngectomy at a large academic center from May 2005 through December 2016 was performed. Airway management was examined, specifically as it pertains to whether a tracheostomy was performed at the time of surgery or otherwise. Demographic and tumor characteristics were also evaluated. Results: Sixty-three patients were included. Forty (63%) were male, the average age at surgery was 63.6, and the majority (90.5%) underwent resection for squamous cell carcinoma of the supraglottis. Thirty-nine patients (62%) underwent the procedure with standard endotracheal intubation using a wire-reinforced tube. Of these, four patients required subsequent tracheostomy- 2 for laryngeal edema postoperatively, one for airway management during a postoperative bleeding event, and one for laryngeal edema following initiation of adjuvant chemoradiation. Twenty patients (32%) underwent tracheostomy at the time of transoral resection for airway management, 17 of whom were decannulated an average of 12.2 weeks following surgery. Those who underwent tracheostomy at the time of surgery had a higher percentage of tumors involving multiple supraglottic subsites (p = 0.031), 85 vs. 54% in the group who did not undergo tracheostomy. No difference in age, BMI, clinical T-stage, or clinical N stage was found between the two groups. Conclusion: Performing a tracheostomy at the time of surgery should be considered for those patients with more extensive malignant disease (≥T2 tumors). While avoiding tracheostomy is often preferred by the patient, the maintenance of the patent airway peri-operatively should be first priority when considering airway management. Furthermore, as the majority of those patients receiving tracheostomy are decannulated within 4 months of surgery, the tracheostomy could be considered a short-term adjunct to the procedure.
- 14 August 2018
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 8, 312
Open AccessManagement of the Airway for Transoral Robotic Supraglottic Partial Laryngectomy
Introduction: Over the last several decades, transoral resection techniques for treatment of supraglottic lesions have become increasingly favored to reduce the need for either open transcervical resection or primary chemoradiation. Transoral robotic surgery (TORS) offers advantages in visualization, dissection control, and access to remove bulky tumors en bloc. However, the management of the airway for these cases tends to vary, without clear guidelines as to when a tracheostomy is necessary. Materials and Methods: A retrospective review of all patients who underwent transoral robotic supraglottic partial laryngectomy at a large academic center from May 2005 through December 2016 was performed. Airway management was examined, specifically as it pertains to whether a tracheostomy was performed at the time of surgery or otherwise. Demographic and tumor characteristics were also evaluated. Results: Sixty-three patients were included. Forty (63%) were male, the average age at surgery was 63.6, and the majority (90.5%) underwent resection for squamous cell carcinoma of the supraglottis. Thirty-nine patients (62%) underwent the procedure with standard endotracheal intubation using a wire-reinforced tube. Of these, four patients required subsequent tracheostomy- 2 for laryngeal edema postoperatively, one for airway management during a postoperative bleeding event, and one for laryngeal edema following initiation of adjuvant chemoradiation. Twenty patients (32%) underwent tracheostomy at the time of transoral resection for airway management, 17 of whom were decannulated an average of 12.2 weeks following surgery. Those who underwent tracheostomy at the time of surgery had a higher percentage of tumors involving multiple supraglottic subsites (p = 0.031), 85 vs. 54% in the group who did not undergo tracheostomy. No difference in age, BMI, clinical T-stage, or clinical N stage was found between the two groups. Conclusion: Performing a tracheostomy at the time of surgery should be considered for those patients with more extensive malignant disease (≥T2 tumors). While avoiding tracheostomy is often preferred by the patient, the maintenance of the patent airway peri-operatively should be first priority when considering airway management. Furthermore, as the majority of those patients receiving tracheostomy are decannulated within 4 months of surgery, the tracheostomy could be considered a short-term adjunct to the procedure.
- 31 October 2017
- Published by Wiley in The Laryngoscope
- Vol. 128 (6) , 1486-1489
Upper airway stimulation therapy and prior airway surgery for obstructive sleep apnea
Objective: To determine if patients with prior airway surgery for obstructive sleep apnea (OSA) had increased benefit following implantation with hypoglossal nerve stimulator.Study Design: Retrospective chart review at a single institution tertiary academic care center.Methods: Following implantation with hypoglossal nerve stimulator device, the outcomes of patients who underwent prior airway surgery for OSA were compared with those who did not. Primary outcome measures included apnea‐hypopnea index (AHI) and nadir oxyhemoglobin saturation (NOS) as measured by polysomnography. Secondary outcome measures included Epworth Sleepiness Scale.Results: Forty‐seven patients underwent implantation with hypoglossal nerve stimulator. Of these, 30 patients had undergone prior airway surgery for OSA, whereas 16 did not. Mean preoperative AHI and NOS were 39.3 ± 2.8 and 78% ± 1.8% for all patients, 39.4 ± 3.7 and 79% ± 14% for patients with prior airway surgery, and 39.1 ± 4.0 and 77% ± 2.6% for patients without prior surgery. Mean postoperative AHI and NOS were 3.9 ± 1.2 and 91% ± 0.4% for all patients, 4.2 ± 1.7 and 91% ± 0.5% for patients with prior surgery, and 3.4 ± 1.5 and 93% ± 0.6% for patients without prior surgery (P = 0.756 and 0.053, respectively).Conclusion: Overall, patients had significant improvement following implantation with hypoglossal nerve stimulator. Prior airway surgery had no statistically significant effect on postoperative AHI or NOS.Level of Evidence: 4. Laryngoscope, 128:1486–1489, 2018
- 31 October 2017
- Published by Wiley in The Laryngoscope
- Vol. 128 (6) , 1486-1489
Upper airway stimulation therapy and prior airway surgery for obstructive sleep apnea
Objective: To determine if patients with prior airway surgery for obstructive sleep apnea (OSA) had increased benefit following implantation with hypoglossal nerve stimulator.Study Design: Retrospective chart review at a single institution tertiary academic care center.Methods: Following implantation with hypoglossal nerve stimulator device, the outcomes of patients who underwent prior airway surgery for OSA were compared with those who did not. Primary outcome measures included apnea‐hypopnea index (AHI) and nadir oxyhemoglobin saturation (NOS) as measured by polysomnography. Secondary outcome measures included Epworth Sleepiness Scale.Results: Forty‐seven patients underwent implantation with hypoglossal nerve stimulator. Of these, 30 patients had undergone prior airway surgery for OSA, whereas 16 did not. Mean preoperative AHI and NOS were 39.3 ± 2.8 and 78% ± 1.8% for all patients, 39.4 ± 3.7 and 79% ± 14% for patients with prior airway surgery, and 39.1 ± 4.0 and 77% ± 2.6% for patients without prior surgery. Mean postoperative AHI and NOS were 3.9 ± 1.2 and 91% ± 0.4% for all patients, 4.2 ± 1.7 and 91% ± 0.5% for patients with prior surgery, and 3.4 ± 1.5 and 93% ± 0.6% for patients without prior surgery (P = 0.756 and 0.053, respectively).Conclusion: Overall, patients had significant improvement following implantation with hypoglossal nerve stimulator. Prior airway surgery had no statistically significant effect on postoperative AHI or NOS.Level of Evidence: 4. Laryngoscope, 128:1486–1489, 2018
- 8 June 2017
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 3 (3) , 122-127
Transoral Robotic Surgery for Obstructive Sleep Apnea
- 8 June 2017
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 3 (3) , 122-127
Transoral Robotic Surgery for Obstructive Sleep Apnea
- 1 December 2014
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 35 (10) , e286-e291
Speech Perception Performance as a Function of Age at Implantation Among Postlingually Deaf Adult Cochlear Implant Recipients
Objective We seek to determine the extent of age-related decline in speech perception performance among cochlear implant recipients as quantified by various metrics. Study Design Retrospective chart review. Setting Tertiary referral center. Patients The records of 70 postlingually deafened adults who received cochlear implants between 2004 and 2013 were reviewed. Intervention(s) Unilateral cochlear implantation. Main Outcome Measure(s) Postoperative AzBio and Consonant-Nucleus-Consonant (CNC) scores at greater than 3 months postactivation. Group analyses comparing patients aged 65 years and older (elderly) with younger adult patients (control). In addition, multivariate linear regression analyses were performed that incorporated preoperative pure-tone audiograms, duration of deafness, duration of follow-up, sex, and laterality of the implanted ear to quantitate the dependence of AzBio and CNC results on age at implantation (AAI). Results Performance on AzBio for the control and elderly groups were 74.6% ± 4.1% and 59.5% ± 4.5% (p = 0.032), respectively. Performance on CNC scores were 63.9% ± 3.4% and 55.3% ± 3.3% (p = 0.098), respectively. Multiple linear regression showed a significant correlation of AzBio with AAI, whereas CNC did not correlate significantly (correlation coefficients = −0.006 and −0.003, p = 0.019 and 0.081, respectively). Conclusion Patients implanted at a later age performed more poorly on AzBio sentences. A similar trend was noted with CNC scores although not significant. The variability in correlation coefficients and significance between both speech perception tests and AAI suggests that, as patients age, their performance on each individual test will be affected to a varying degree.
- 1 December 2014
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 35 (10) , e286-e291
Speech Perception Performance as a Function of Age at Implantation Among Postlingually Deaf Adult Cochlear Implant Recipients
Objective We seek to determine the extent of age-related decline in speech perception performance among cochlear implant recipients as quantified by various metrics. Study Design Retrospective chart review. Setting Tertiary referral center. Patients The records of 70 postlingually deafened adults who received cochlear implants between 2004 and 2013 were reviewed. Intervention(s) Unilateral cochlear implantation. Main Outcome Measure(s) Postoperative AzBio and Consonant-Nucleus-Consonant (CNC) scores at greater than 3 months postactivation. Group analyses comparing patients aged 65 years and older (elderly) with younger adult patients (control). In addition, multivariate linear regression analyses were performed that incorporated preoperative pure-tone audiograms, duration of deafness, duration of follow-up, sex, and laterality of the implanted ear to quantitate the dependence of AzBio and CNC results on age at implantation (AAI). Results Performance on AzBio for the control and elderly groups were 74.6% ± 4.1% and 59.5% ± 4.5% (p = 0.032), respectively. Performance on CNC scores were 63.9% ± 3.4% and 55.3% ± 3.3% (p = 0.098), respectively. Multiple linear regression showed a significant correlation of AzBio with AAI, whereas CNC did not correlate significantly (correlation coefficients = −0.006 and −0.003, p = 0.019 and 0.081, respectively). Conclusion Patients implanted at a later age performed more poorly on AzBio sentences. A similar trend was noted with CNC scores although not significant. The variability in correlation coefficients and significance between both speech perception tests and AAI suggests that, as patients age, their performance on each individual test will be affected to a varying degree.